Molecular mimicry in autoimmune disease

Archives of Disease in Childhood

Volumn 79, Issue 5, 1998, Pages 448-451

  Leech, Susan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN;

ADENOVIRUS; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELIAC DISEASE; COXSACKIE VIRUS; HELPER CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0031732167     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.5.448     Document Type: Review

References (28)

1. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.
2. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989;56:849-53.
3. McDougal JS, Nicholson JK, Cross GD, Cort SP, Kennedy MS, Mawle AC. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 1986; 137:2937-44.
4. Baum H, Davies H, Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996;17:64-70.
5. Seager K, Bashir HV, Geczy AF, Edmonds J, de-vere-Tyndall A. Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979;277:68-70.
6. Williams KM, Hirofuji T, Raybourne RB, Shook DL, Trucksess MW, Yu DT. Synthetic oligonucleotide probes complementary to the HLA-B variable region hybridize with Klebsiella pneumoniae. Microb Pathog 1989;6:277-86.
7. Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971;ii:332-4.
8. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993;178:27-47.
9. Honeyman MC, Cram DS, Harrison LC. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 1993;42:626-30.
10. Rabin DU, Pleasic SM, Shapiro JA, et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994;152:3183-8.
11. Szopa TM, Ward T, Dronfield DM, Portwood ND, Taylor KW. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990;33:325-8.
12. Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996;39:1318-24.
13. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994;43:1260-6.
14. Hyoty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood diabetes in Finland (DiMe) study group. Diabetes 1995;44:652-7.
15. Lonnrot M, Hyoty H, Knip M, et al. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Clin Exp Immunol 1996;104:398-405.
16. Hiltunen M, Hyoty H, Knip M, et al. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997;175:554-60.
17. Virtanen SM, Saukkonen T, Savilahti E, et al. Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children. Diabetologia 1994;37:381-7.
18. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P. Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996;348:926-8.
19. Paronen J, Vaarala O, Savilahti E, Saukkonen T, Akerblom HK. Soluble adhesion molecules and oral antigen feeding in infants. Pediatr Res 1996;40:276-9.
20. Karjalainen J, Martin JM, Knip M, et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992;327:302-7.
21. Inman LR, McAllister CT, Chen L, et al. Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin-dependent diabetes mellitus of recent onset. Proc Natl Acad Sci USA 1993;90:1281-4.
22. Kagnoff MF, Paterson YJ, Kumar PJ, et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995-1001.
23. Mantzaris G, Jewell DP. In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. Scand J Gastroenterol 1991;26:392-8.
24. Ellis HJ, Doyle AP, Sturgess RP, Ciclitira PJ. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin. Gut 1992;33:1504-7.
25. Mahon J, Blair GE, Wood GM, Scott BB, Losowsky MS, Howdle PD. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut 1991;32:1114-16.
26. Carter MJ, Willcocks MM, Mitchison HC, Record CO, Madeley CR. Is a persistent adenovirus infection involved in coeliac disease? Gut 1989;30:1563-7.
27. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993;341:927-8.
28. Parent ME, Siemiatycki J, Menzies R, Fritschi L, Colle E. Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997;20:767-2.